BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38334028)

  • 1. Pancreatic Adenocarcinoma Resectability Assessment: Could a Visual Aid Tool Save Both Patients and Radiology Residents?
    Rogalla P; Cadour F; Kim TK
    Can Assoc Radiol J; 2024 Feb; ():8465371241230905. PubMed ID: 38334028
    [No Abstract]   [Full Text] [Related]  

  • 2. A Visual Aid Tool for Detection of Pancreatic Tumour-Vessel Contact on Staging CT: A Retrospective Cohort Study.
    Policelli R; Dammak S; Ward AD; Kassam Z; Johnson C; Ramsewak D; Syed Z; Siddiqi L; Siddique N; Kim D; Marshall H
    Can Assoc Radiol J; 2023 Dec; ():8465371231217155. PubMed ID: 38124063
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic response assessment in pancreatic ductal adenocarcinoma: society of abdominal radiology review paper on the role of morphological and functional imaging techniques.
    Wang ZJ; Arif-Tiwari H; Zaheer A; Ameli S; Bhosale PR; Do RK; Goenka AH; Guimares AR; Sangster GP; Soloff EV; Tamm EP; Zins M; Kambadakone AR
    Abdom Radiol (NY); 2020 Dec; 45(12):4273-4289. PubMed ID: 32936417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Inflammatory Markers in Predicting Resectability of Pancreatic Ductal Adenocarcinoma.
    Agalianos C; Gouvas N; Manatakis DK; Sideris I; Passas I; Dervenis C
    Chirurgia (Bucur); 2022 Jun; 117(4):431-436. PubMed ID: 36049100
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma.
    Lee JK; Kim AY; Kim PN; Lee MG; Ha HK
    Eur J Radiol; 2010 Feb; 73(2):310-6. PubMed ID: 19070981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma.
    Ahmad NA; Lewis JD; Siegelman ES; Rosato EF; Ginsberg GG; Kochman ML
    Am J Gastroenterol; 2000 Aug; 95(8):1926-31. PubMed ID: 10950037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Color flow sonography in evaluating the resectability of periampullary and pancreatic tumors.
    Ralls PW; Wren SM; Radin R; Stain SC; Yang J; Parekh D
    J Ultrasound Med; 1997 Feb; 16(2):131-40. PubMed ID: 9166806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDCT in Pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations.
    Vargas R; Nino-Murcia M; Trueblood W; Jeffrey RB
    AJR Am J Roentgenol; 2004 Feb; 182(2):419-25. PubMed ID: 14736675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resectability of pancreatic adenocarcinoma in patients with locally advanced disease downstaged by preoperative therapy: a challenge for MDCT.
    Morgan DE; Waggoner CN; Canon CL; Lockhart ME; Fineberg NS; Posey JA; Vickers SM
    AJR Am J Roentgenol; 2010 Mar; 194(3):615-22. PubMed ID: 20173136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors of resectability of pancreatic adenocarcinoma.
    Almadi MA; Alharbi O; Azzam N; Altayeb M; Javed M; Alsaif F; Hassanain M; Alsharabi A; Al-Saleh K; Aljebreen AM
    Saudi J Gastroenterol; 2013; 19(6):278-85. PubMed ID: 24195982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association.
    Al-Hawary MM; Francis IR; Chari ST; Fishman EK; Hough DM; Lu DS; Macari M; Megibow AJ; Miller FH; Mortele KJ; Merchant NB; Minter RM; Tamm EP; Sahani DV; Simeone DM
    Gastroenterology; 2014 Jan; 146(1):291-304.e1. PubMed ID: 24355035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort.
    Herreros-Villanueva M; Ruiz-Rebollo L; Montes M; Rodriguez-Lopez M; Francisco M; Cubiella J; Iyo E; Garabitos E; Martínez Moneo E; Martos M; de Madaria E; Martínez-Arránz I; García-Cougil M; Iglesias-Gómez A; Bujanda L
    Mol Biol Rep; 2020 Mar; 47(3):1583-1588. PubMed ID: 31915999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of multi-detector computerized tomography scan, endoscopic ultrasound, and laparoscopy for predicting tumor resectability in pancreatic adenocarcinoma.
    Baghbanian M; Salmanroghani H; Baghbanian A; Bakhtpour M; Shabazkhani B
    Indian J Gastroenterol; 2013 Nov; 32(6):376-80. PubMed ID: 23982702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resectability of pancreatic adenocarcinoma: assessment using multidetector-row computed tomography with multiplanar reformations.
    Manak E; Merkel S; Klein P; Papadopoulos T; Bautz WA; Baum U
    Abdom Imaging; 2009; 34(1):75-80. PubMed ID: 17934772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
    Kim YC; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Shin JH
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1869-75. PubMed ID: 19686409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery.
    Valls C; Andía E; Sanchez A; Fabregat J; Pozuelo O; Quintero JC; Serrano T; Garcia-Borobia F; Jorba R
    AJR Am J Roentgenol; 2002 Apr; 178(4):821-6. PubMed ID: 11906855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic adenocarcinoma: combination of MR imaging, MR angiography and MR cholangiopancreatography for the diagnosis and assessment of resectability.
    Catalano C; Pavone P; Laghi A; Panebianco V; Scipioni A; Fanelli F; Brillo R; Passariello R
    Eur Radiol; 1998; 8(3):428-34. PubMed ID: 9510578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiologic resectability assessment in pancreatic cancer.
    Denecke T; Grieser C; Neuhaus P; Bahra M
    Rofo; 2014 Jan; 186(1):23-9. PubMed ID: 24081785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA 19-9 predicts resectability of pancreatic cancer even in jaundiced patients.
    Santucci N; Facy O; Ortega-Deballon P; Lequeu JB; Rat P; Rat P
    Pancreatology; 2018 Sep; 18(6):666-670. PubMed ID: 30153902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis.
    Bipat S; Phoa SS; van Delden OM; Bossuyt PM; Gouma DJ; Laméris JS; Stoker J
    J Comput Assist Tomogr; 2005; 29(4):438-45. PubMed ID: 16012297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.